Association between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissues.

Association between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissues.
复制标题

DOI:
10.1186/s12935-015-0214-0
复制
发表时间:
2015
影响因子:
5.8
通讯作者:
Chen G
Chen G
中科院分区:
医学2区
文献类型:
--
作者:
Liu Y;Ren F;Rong M;Luo Y;Dang Y;Chen G

文献摘要

参考文献

被引文献

相似文献

尽管最近的研究已经显示了miR-203作为癌症相关生物标志物的效用,但miR-203在HCC中的经验证的临床意义仍然不清楚。本研究的目的是评估miR-203表达与HCC患者临床病理特征之间的关系。通过定量逆转录聚合酶链反应(qRT-PCR)评估95例福尔马林固定、石蜡包埋(FFPE)的HCC组织及其配对的相邻非癌组织中miR-203的表达。同时,分析miR-203的表达及其与各种临床病理参数和患者复发的相关性。miR-203在肝癌组织中的相对表达水平为1.1651 ± 0.70378,显著低于癌旁肝组织中的相对表达水平(2.2408 ± 0.75351,P < 0.001)。miR-203低表达诊断HCC的曲线下面积(AUC)为0.85(95% CI:0.796 ~ 0.904,P = 0.027),以miR-203在所有组织(包括HCC和正常肝组织)中的中位表达评估的截止值为1.99。miR-203的表达与肿瘤转移呈负相关(r =-0.254,P = 0.013),临床肿瘤淋巴结转移(TNM)分期(r =-0.300,P = 0.003),nm 23表达p21表达(r =-0.223,P = 0.030)、微血管密度(r =-0.206,P = 0.045)与肝硬化的发生呈正相关(r = 0.487,P < 0.001)。miR-203低表达组复发时间(57.949 ± 4.184)个月略长于高表达组(54.682 ± 2.591)个月,但差异无统计学意义(χ 2 = 0.206,P = 0.650)。MiR-203在HCC的发生、发展中起着重要作用,可作为HCC恶化的预测因子。miR-203可能成为肝癌分子治疗的新靶点。
Although recent studies have shown the utility of miR-203 as a cancer-relevant biomarker, the validated clinical significance of miR-203 in HCC remains obscure. The aim of the present study was to evaluate the relationship between miR-203 expression and clinicopathological features in HCC patients. MiR-203 expression in 95 formalin-fixed, paraffin embedded (FFPE) HCC tissues and their paired adjacent non-cancerous tissues was evaluated by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Simultaneously, expression of miR-203 and its correlation with a variety of clinicopathological parameters and patient recurrence was analyzed. The relative level of miR-203 was 1.1651 ± 0.70378 in HCC tissues, significantly lower than its expression in the corresponding adjacent non-cancerous liver tissues (2.2408 ± 0.75351, P < 0.001). The area under curve (AUC) of low miR-203 expression to diagnose HCC was 0.85 (95 % CI: 0.796 ~ 0.904, P = 0.027) at a cut-off value 1.99 evaluated by the median expression of miR-203 in all tissues, including HCC and normal liver tissues. Expression of miR-203 was negatively correlated to metastasis (r = −0.254, P = 0.013), clinical tumor nodes metastasis (TNM) stage (r = −0.300, P = 0.003), nm23 expression (r = −0.292, P = 0.004), p21 expression (r = −0.223, P = 0.030), microvessel density (MVD)(r = −0.206, P = 0.045) and was positively correlated to cirrhosis (r = 0.487, P < 0.001). Additionally, the recurrent time of lower miR-203 expression group was 57.949 ± 4.184 months, slightly longer than that in the high expression group (54.682 ± 2.591 months), however, no significant difference was noted (Chi-square = 0.206, P = 0.650). MiR-203 plays a vital role in the carcinogenesis and progression of HCC, which makes itself as a predictor for the deterioration of HCC. Furthermore, miR-203 may become a new target for molecular therapy in HCC.
DOI: 10.1002/hep.25832
发表时间: 2013-04
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Roayaie, Sasan;Obeidat, Khaled;Sposito, Carlo;Mariani, Luigi;Bhoori, Sherrie;Pellegrinelli, Alessandro;Labow, Daniel;Llovet, Josep M.;Schwartz, Myron;Mazzaferro, Vincenzo
通讯作者: Mazzaferro, Vincenzo
DOI: 10.1159/000350125
发表时间: 2013-01-01
影响因子: --
作者:
Zhu, Xiangyu;Er, Kejun;Shi, Hong
通讯作者: Shi, Hong
基于肝细胞癌的肝血液动力学基于经导管动脉化学栓塞。
DOI: 10.1155/2013/479805
发表时间: 2013
影响因子: --
作者:
Murata S;Mine T;Ueda T;Nakazawa K;Onozawa S;Yasui D;Kumita S
通讯作者: Kumita S
DOI: 10.1001/jama.299.4.425
发表时间: 2008-01-30
影响因子: 120.7
作者:
Schetter, Aaron J.;Leung, Suet Yi;Harris, Curtis C.
通讯作者: Harris, Curtis C.
DOI: 10.4161/cc.10.7.15180
发表时间: 2011-04-01
期刊: CELL CYCLE
影响因子: 4.3
作者:
Viticchie, Giuditta;Lena, Anna Maria;Melino, Gerry
通讯作者: Melino, Gerry